The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.
Medtronic (NYSE:MDT) recently lost a major antitrust lawsuit that resulted in a multi hundred million dollar damages award ...
Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.
Medtronic earned the FDA’s 510(k) clearance for its Stealth AXiS system that brings planning, navigation and robotics into ...
Grounded in more than 50 years of Medtronic leadership in surgical navigation and robotics, the Stealth AXiS™ system creates a clear pathway for adoption by combining familiar navigation workflows ...
On Friday, the U.S. Food and Drug Administration cleared Medtronic plc’s MDT Stealth AXiS surgical system for spine surgery. The Stealth AXiS system is cleared for spine procedures in the United ...